Amphastar has three Research and Development facilities:
•Amphastar Pharmaceuticals in Rancho Cucamonga, California,
•New Drug Research Center in Chino, California and
• Amphastar Nanjing Pharmaceuticals in Nanjing, China
As we have expanded our infrastructure and strengthened our research and development expertise in injectables and inhalation products, our strategic focus has evolved into developing products for large patient markets with high technical barriers to entry.
We are specifically focused on applying our technical expertise to develop products that:
•Require an active pharmaceutical ingredient, or API, that is difficult to source and/or manufacture;
•Involve difficult and complex manufacturing processes;
•Improve the innovator’s formulation to provide better drug delivery safety and/or efficiency; and/or
•Use our proprietary drug delivery technology and platforms.
Through our research and development efforts, we have developed several proprietary technologies, or platforms, focused on the improvement of drug delivery efficiency for injectable and inhalation products, which we believe will prove invaluable in our on-going product development efforts.
We have made and expect to continue to make substantial investments in research and development to expand our product portfolio and grow our business.